This page shows the latest NHS news and features for those working in and with pharma, biotech and healthcare.
A research-active NHS delivers huge value to patients, staff and the system itself. ... Around 25% of the world’s top 100 prescription medicines are discovered and developed in the UK, according to NHS England.
The Association of the British Pharmaceutical Industry (ABPI) has published a new set of proposals for the UK government aimed at supporting both the NHS and economy. ... The current VPAG, introduced in 2019, caps the growth of NHS branded medicine
NHS patient access to innovative medicines all across the UK,” adding that the UK has traditionally been a “strong global location for trials”. ... is critical if we are to deliver the UK’s ambitions for the life sciences sector and to support
the NHS can continue to deliver maximum value to the taxpayer.”.
In November 2022, researchers from the ICR and the Royal Marsden NHS Foundation Trust revealed joint plans to create a new generation of treatments that target the ecosystems within the body
Sanofi has announced that its long-term enzyme replacement therapy will now be available on the NHS to patients with Pompe disease, following a recommendation from the National Institute for Health
More from news
Approximately 427 fully matching, plus 1,895 partially matching documents found.
For example, the National Health Service (NHS) in the UK is updating a mobile application that improves access to healthcare services nationally.
This resulted in an 80% reduction of heart failure hospitalisations within just five months of monitoring, which is not only beneficial for patients, but also for the NHS, with each complex
In the recent NHS paper on Delivering a ‘Net Zero’ National Health Service, one of the main challenges for the pharmaceutical industry is how to reduce emissions from medicines, which currently
NHS in England has given its supply chain five years to fall in line with its plans to hit carbon net zero by 2045.
For example, the UK’s NHS and the EU’s European Medicines Agency both have updated guidance on BYOD for healthcare staff and for clinical trials.
More from intelligence
Approximately 34 fully matching, plus 215 partially matching documents found.
Mole joins the agency from his previous role as deputy director of communications at NHS England and will report to leads Alex Davies and Emma Gorton. ... He also worked closely with leading medics, including NHS national medical director Professor Sir
Dodge was the former national director of strategy, primary care and community services for NHS England. ... Hanover Health – part of the Hanover Group – has announced that it has appointed former NHS England national director of strategy, primary
With over 225 members, NHS Providers is the membership organisation for the NHS acute hospitals and community, mental health and ambulance services. ... Chris has led NHS Providers with rigour and determination over the last ten years and has been a
She first joined the NHS as a graduate management trainee in 1997 after graduating from Oxford University. ... She has held a variety of additional NHS management positions over the course of her career.
First launched in 2012, the 100, 000 Genome Project had ambitious plans to map the genomes of NHS patients to deliver treatments for those with rare inherited diseases and cancer. ... of Health and Social Care, Office for Life Sciences, London Borough of
More from appointments
Approximately 18 fully matching, plus 98 partially matching documents found.
One report by the NHS Confederation highlights the key barriers to PSP uptake, noting lack of awareness of PSPs for both patients and healthcare professionals (HCPs see below) as a key
18. The product was such a success that it is now offered to affected women via the NHS. ... Published September 10, 2018. Accessed November 4, 2021. Wilkinson E. NICE: More evidence needed before NHS can adopt use of contraception app.
to access care in a more convenient, personalised and consumer-centric manner.As a key goal set out in the NHS Long Term Plan, the concept of personalised care isn’t ... However, for women to truly benefit, the NHS and the Femtech industry must work as
Deterring investment in the UK will mean new treatments get into NHS referral pathways later, or not at all. ... sciences sector to deliver new medical innovations to NHS patients and the wider public.
Prioritising the prevention of cardiovascular disease (CVD) should be at the heart of plans to safeguard the long-term sustainability of the NHS. ... This is money that could make a significant difference to an NHS creaking under its current burden.
More from PMHub
Approximately 63 fully matching, plus 273 partially matching documents found.
PMEA Agency of the year 2021. With diversity and inclusion at our core, Mednet Group consists of Attigo CIC and...